keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CFSE (CFDA-SE) 属于荧光染料,具有细胞膜渗透性。CFSE 可在活细胞内与胞内蛋白进行不可逆的结合,用于检测细胞增殖,标记的细胞呈绿色荧光,激发波长为 488 nm,发射波长为 518 nm。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 196 | 现货 | ||
5 mg | ¥ 453 | 现货 | ||
10 mg | ¥ 659 | 现货 | ||
25 mg | ¥ 1,290 | 现货 | ||
50 mg | ¥ 1,970 | 现货 | ||
100 mg | ¥ 2,880 | 现货 | ||
200 mg | ¥ 4,270 | 现货 | ||
500 mg | ¥ 6,820 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 783 | 现货 |
产品描述 | CFSE (CFDA-SE) is a fluorescent dye with cell membrane permeability. CFSE irreversibly binds to intracellular proteins in living cells and is used for the detection of cell proliferation. The labeled cells fluoresce in green color with excitation wavelength of 488 nm and emission wavelength of 518 nm. |
体外活性 |
方法:将 1 mL 细胞和 CFDA (5 mM in 110μL PBS) 翻转混匀以标记细胞。CFSE 标记的 CD8+OT-I T 细胞与用不同量的 OVA 脉冲的树突细胞培养 3 天,使用 Flow Cytometry 检测 CFSE 图谱。 结果:CD8+ T 细胞根据 CFSE 稀释峰分裂 1-3 次,更多的 T 细胞在较高的抗原浓度下分裂。[1] 方法:人红白血病细胞系K562、小鼠淋巴瘤细胞系YAC-1、人乳腺癌症细胞 MCF-7 和 人黑色素瘤细胞系 A375 用 CFDA (1-10 mM) 处理 1-6 h,使用 Flow Cytometry 检测细胞死亡情况。 结果:CFDA 对细胞无毒,因为 CFDA 标记引起的细胞死亡率低于 5%。[2] |
体内活性 |
方法:CFSE 标记的 CD8+OT-I T 细胞尾静脉注射给 C56BL/6J 小鼠,随后静脉注射 OVA (20 μg),三天后检测 CFSE 图谱。 结果:大多数细胞落在 7 个 CFSE 峰值内,这表明细胞已经经历了多达 6 次分裂。[1] 方法:为在体内标记胸腺细胞,将 CFDA (10 μM) 注射到麻醉 C56BL/6 小鼠的胸腺叶。 结果:CFDA 标记了所有胸腺细胞亚群的代表性样本,并且这些细胞以大约 2-3×10^6 个细胞/天的速率迁移到外周淋巴器官。它们在注射后第 1 天进入淋巴结,并停留至少 21 天,而在脾脏中的周转更快。[3] |
细胞实验 | The 5 mM CFDA-SE stock in DMSO is diluted to different concentrations(2 μM, 3 μM, 4 μM, 5 μM, 10 μM and 20 μM) in PBS with a total volume of 1 ml. After each cell line is harvested and washed three times with PBS, 1×109 cells are added to equal volume of CFDA-SE with different concentrations and incubated at 37°C for 5, 6, 7, 8, 10 and 15 min with agitation. The labeling reaction is stopped for 1 min by adding an equal volume of heat inactivated fetal bovine serum. The CFDA-SE labeled cells are washed twice with PBS and recounted, and the cell concentration is adjusted to 6×104cells/ml in IMDM containing 10% FCS.(Only for Reference) |
别名 | 5(6)-CFDA N-succinmidyl ester, Carboxyfluorescein succinimidyl ester, CFDA-SE, 5(6)-羧基二乙酸荧光素琥珀酰亚胺酯, 5(6)-Carboxyfluorescein diacetate succinimidyl ester |
分子量 | 557.46 |
分子式 | C29H19NO11 |
CAS No. | 150347-59-4 |
keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 93 mg/mL (166.8 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.7939 mL | 8.9693 mL | 17.9385 mL | 44.8463 mL |
5 mM | 0.3588 mL | 1.7939 mL | 3.5877 mL | 8.9693 mL | |
10 mM | 0.1794 mL | 0.8969 mL | 1.7939 mL | 4.4846 mL | |
20 mM | 0.0897 mL | 0.4485 mL | 0.8969 mL | 2.2423 mL | |
50 mM | 0.0359 mL | 0.1794 mL | 0.3588 mL | 0.8969 mL | |
100 mM | 0.0179 mL | 0.0897 mL | 0.1794 mL | 0.4485 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CFSE 150347-59-4 Others Inhibitor 5(6)-CFDA N-succinmidyl ester Carboxyfluorescein succinimidyl ester CFDA-SE 5(6)-羧基二乙酸荧光素琥珀酰亚胺酯 5(6)-Carboxyfluorescein diacetate succinimidyl ester inhibit inhibitor